Join
Live feed
·
INSIDERFilingvia Quantisnow
X4 Pharmaceuticals Inc. logo

Chief Medical Officer Arbet-Engels Christophe was granted 850,000 shares, increasing direct ownership by 5,983% to 864,207 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XFOR· X4 Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XFOR (X4 Pharmaceuticals Inc.) and more on Quantisnow.